Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection may cause hair loss.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

COVID-19 may cause temporary hair loss due to the body's immune response.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

COVID-19 may trigger sudden temporary hair loss.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Minoxidil treatment may cause hair loss.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

Trichoscopy is an effective, non-invasive way to diagnose telogen effluvium.

Severe COVID-19 increases the risk of hair loss.

Monocytes might be linked to hair loss after COVID-19.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

People with TED often have low B12 levels and might benefit from B12 supplements.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Topical Minoxidil is effective for hair loss after COVID-19.

Telogen effluvium patients have a worse quality of life, but similar self-esteem compared to others.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.